Toth Financial Advisory’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-750	Closed	-$17.5K	–	951
2025 Q4	$17.5K	Sell	750 -1,400	-65%	-$31.2K	﹤0.01%	489
2025 Q3	$42.4K	Sell	2,150 -59,200	-96%	-$1.22M	﹤0.01%	376
2025 Q2	$1.33M	Buy	61,350 +1,825	+3%	+$43.1K	0.16%	110
2025 Q1	$1.44M	Buy	59,525 +5,275	+10%	+$119K	0.17%	108
2024 Q4	$1.13M	Buy	54,250 +3,750	+7%	+$80.6K	0.13%	119
2024 Q3	$1M	Buy	+50,500	New	+$936K	0.12%	122
2024 Q2	–	Sell	-33,800	Closed	-$539K	–	760
2024 Q1	$539K	Buy	33,800 +31,300	+1,252%	+$472K	0.07%	160
2023 Q4	$42K	Hold	2,500	–	–	0.01%	311
2023 Q3	$29.2K	Hold	2,500	–	–	﹤0.01%	318
2023 Q2	$33.6K	Hold	2,500	–	–	﹤0.01%	317
2023 Q1	$41.5K	Buy	2,500 +2,000	+400%	+$33K	0.01%	293
2022 Q4	$9.3K	Hold	500	–	–	﹤0.01%	449
2022 Q3	$6K	Buy	+500	New	+$5.93K	﹤0.01%	530